NASDAQ:MIRA

MIRA Pharmaceuticals Earnings Date & Estimates

MIRA Pharmaceuticals logo
$0.59 -0.05 (-7.66%)
Closing price 11/18/2026 04:00 PM Eastern
Extended Trading
$0.60 +0.01 (+1.18%)
As of 11/18/2026 07:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MIRA Pharmaceuticals is estimated to report earnings on Wednesday, December 2, 2026.

What Analysts Expect from MIRA Pharmaceuticals

MIRA Pharmaceuticals is expected to post earnings of -$0.03 per share. In the same quarter a year earlier MIRA Pharmaceuticals reported -$1.18 per share. MIRA Pharmaceuticals last reported on November 16, 2026, posting -$0.03 per share and matching the -$0.03 consensus estimate. MIRA Pharmaceuticals has beaten the consensus EPS estimate in 4 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.03
Prior-Year EPS
-$1.18

Recent Track Record

Last Reported
Q3 2026
Last Quarter EPS
-$0.03 (Met Expectations)
EPS Beat Rate
4 of last 8 quarters

MIRA Pharmaceuticals Earnings FAQ

MIRA Pharmaceuticals (NASDAQ:MIRA) is estimated to report earnings on Wednesday, December 2, 2026. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect MIRA Pharmaceuticals to post earnings of -$0.03 per share for the quarter.

MIRA Pharmaceuticals Earnings Headlines

I'm handing you this stock today
Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.tc pixel
MIRA Pharmaceuticals (NASDAQ:MIRA) Shares Up 0.3% - Time to Buy?
See More MIRA Pharmaceuticals Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like MIRA Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MIRA Pharmaceuticals and other key companies, straight to your email.

About MIRA Pharmaceuticals

MIRA Pharmaceuticals (NASDAQ:MIRA) is a clinical-stage pharmaceutical company developing oral drug candidates for neurological and neuropsychiatric conditions. Its pipeline includes MIRA1a, an investigational synthetic cannabinoid analog being studied for potential use in conditions such as anxiety and chronic pain.

The company has also added Ketamir-2, an investigational oral ketamine analog being developed for potential treatment of depression and neuropathic pain. These candidates remain in development and are not approved medicines.

View MIRA Pharmaceuticals Profile